Dexmedetomidine Injection, Solution
Product Images NDC 66794-233

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexmedetomidine (NDC 66794-233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Piramal Critical Care Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Packaging label for Dexmedetomidine Injection, USP, 200 mcg/2 mL (100 mcg/mL) intravenous injection solution. The label specifies preservative-free single-dose 2 mL fliptop vials, with 25 vials per carton. Manufactured by Piramal Critical Care Inc and branded as Novaplus. Includes dosage and storage instructions, barcode, NDC 66794-233-42, and carton partition details.*

FDA Label Image

Label (Label)

Label for Dexmedetomidine Injection, USP, 200 mcg/2 mL (100 mcg/mL) single-dose vial by Piramal Critical Care Inc. The label specifies intravenous use requiring dilution and shows NDC 66794-233-02. Additional details include lot, expiration fields, barcode, manufacturer location in Bethlehem, PA, and product origin in India with a 2020 manufacture date.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Dexmedetomidine hydrochloride showing its molecular components including methyl groups and an imidazole ring, represented with standard chemical notation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.